Threshold Pharma (THLD) Updates on Evofosfamide Program; Key Licensing Terms Forged with Merck KGaA
Threshold Pharma (NASDAQ: THLD) announced an update on its evofosfamide program including that Threshold and Merck KGaA, Darmstadt, Germany have ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)